Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.
about
β-Adrenergic Receptor Signaling in Prostate CancerHigh progesterone receptor expression in prostate cancer is associated with clinical failure.Cancer-Associated Stroke: The Bergen NORSTROKE StudyEstrogen receptors α and β and aromatase as independent predictors for prostate cancer outcomeDiabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.Perineural Invasion and Risk of Lethal Prostate Cancer.Perineural invasion is an independent predictor of biochemical recurrence of prostate cancer after local treatment: a meta-analysis.High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrenceFibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) study.The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort.Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively.
P2860
Q28084943-AD985357-D063-4752-B066-FB0EEF8AE7EDQ35130208-FBCBCA28-D0B0-4A56-A336-72A0FF687267Q36325941-403DA10D-B05D-4263-B04D-BA80D5BA94F4Q37244198-44AFC863-F0A5-4835-A4FF-B63A0A182B7BQ37658406-4BD99E3A-94DA-4673-80C6-4E10977ACCC3Q38974777-1B1793E7-1ADC-42BD-B18F-B54BE70315E3Q39035046-C3053A7F-31D4-43E6-B4E1-9ACAFF53BB9CQ41905532-87E1E26D-2BF7-44FE-8589-0A07813ED836Q41967756-6EFBAEB1-752F-4A5D-9455-DBB1D26D9BB7Q41991354-607ADC20-A958-4C41-85F0-05AC94C9178BQ42265633-ECAFCE30-88FC-445D-80C2-6CBC2BCE11B6Q44673099-D1DE0165-F58E-4C57-A34C-AFE0AF7030A6Q47123783-FD8FCC90-897D-4EE6-87D7-CD4C3754C06BQ47135859-7E0AF269-1306-4945-B789-0C0FF37A03A1Q55095968-8344958E-B950-4D7A-9191-94A36DF670F2
P2860
Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Disease-specific outcomes of r ...... stoperative PSA-doubling time.
@ast
Disease-specific outcomes of r ...... stoperative PSA-doubling time.
@en
type
label
Disease-specific outcomes of r ...... stoperative PSA-doubling time.
@ast
Disease-specific outcomes of r ...... stoperative PSA-doubling time.
@en
prefLabel
Disease-specific outcomes of r ...... stoperative PSA-doubling time.
@ast
Disease-specific outcomes of r ...... stoperative PSA-doubling time.
@en
P2093
P2860
P356
P1433
P1476
Disease-specific outcomes of r ...... stoperative PSA-doubling time.
@en
P2093
Anders Angelsen
Elin Richardsen
Helena Bertilsson
Khalid Al-Shibli
Lill-Tove Busund
Oystein Størkersen
Roy M Bremnes
Sigve Andersen
Tom Donnem
P2860
P356
10.1186/1471-2490-14-49
P577
2014-06-14T00:00:00Z